Cunte N. Chen

Guangzhou, 510180, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 58 publications

Optimal combination of immune cells for predicting outcomes in ESCC patients following neoadjuvant immunochemotherapy: Results from a prospective phase II trial.

Optimal combination of immune cells for predicting outcomes in ESCC patients following neoadjuvant immunochemotherapy: Results from a prospective phase II trial.

Journal: Genes & diseases
Published: September 18, 2025

Synergistic effects between CD36 monoclonal antibody and cytarabine for treatment of AML.

Synergistic effects between CD36 monoclonal antibody and cytarabine for treatment of AML.

Journal: European journal of pharmacology
Published: September 17, 2025

PD-1 and LAG-3 were optimal combination of immune checkpoints for predicting poor clinical outcomes of patients with ovarian cancer.

PD-1 and LAG-3 were optimal combination of immune checkpoints for predicting poor clinical outcomes of patients with ovarian cancer.

Journal: Frontiers in immunology
Published: June 29, 2025

High expression of CCL3/CCL4/CCL5/CCR5 promotes exhausted CD8+ T cells terminal differentiation and is associated with poor prognosis in pediatric B-ALL patients.

High expression of CCL3/CCL4/CCL5/CCR5 promotes exhausted CD8+ T cells terminal differentiation and is associated with poor prognosis in pediatric B-ALL patients.

Journal: International journal of immunopathology and pharmacology
Published: June 16, 2025

The role of YTHDF2 in anti-tumor immunity.

The role of YTHDF2 in anti-tumor immunity.

Journal: Cell investigation
Published: March 17, 2025

METTL16 in cancer: Roles and regulatory mechanisms.

METTL16 in cancer: Roles and regulatory mechanisms.

Journal: Genes & diseases
Published: March 13, 2025

Synergistic effects of BET inhibitors and ferroptosis inducers via targeted inhibition of the BRD4/c-Myc/NRF2 pathway in AML.

Synergistic effects of BET inhibitors and ferroptosis inducers via targeted inhibition of the BRD4/c-Myc/NRF2 pathway in AML.

Journal: European journal of pharmacology
Published: February 20, 2025

STAT1 inhibition promotes oxidative stress to sustain leukemia stem cell maintenance.

STAT1 inhibition promotes oxidative stress to sustain leukemia stem cell maintenance.

Journal: Cellular signalling
Published: December 18, 2024

Gene Signature-Based Prognostic Model for Acute Myeloid Leukemia: The Role of BATF, EGR1, PD-1, PD-L1, and TIM-3.

Gene Signature-Based Prognostic Model for Acute Myeloid Leukemia: The Role of BATF, EGR1, PD-1, PD-L1, and TIM-3.

Journal: International journal of medical sciences
Published: December 10, 2024

AGR, LMR and SIRI are the optimal combinations for risk stratification in advanced patients with non-small cell lung cancer following immune checkpoint blockers.

AGR, LMR and SIRI are the optimal combinations for risk stratification in advanced patients with non-small cell lung cancer following immune checkpoint blockers.

Journal: International immunopharmacology
Published: December 04, 2024

Increased Co-Expression of PD-L1 and CTLA-4 Predicts Poor Overall Survival in Patients with Acute Myeloid Leukemia Following Allogeneic Hematopoietic Stem Cell Transplantation.

Increased Co-Expression of PD-L1 and CTLA-4 Predicts Poor Overall Survival in Patients with Acute Myeloid Leukemia Following Allogeneic Hematopoietic Stem Cell Transplantation.

Journal: ImmunoTargets and therapy
Published: October 13, 2024

BRD4 inhibitor reduces exhaustion and blocks terminal differentiation in CAR-T cells by modulating BATF and EGR1.

BRD4 inhibitor reduces exhaustion and blocks terminal differentiation in CAR-T cells by modulating BATF and EGR1.

Journal: Biomarker research
Published: August 13, 2024
Showing 1-12 of 58

Last Updated: 09/26/2026